In the present study, we report that the levels of synaptotagmin-1 were significantly increased in patients with MCI due to Alzheimer’s disease and patients with dementia due to Alzheimer’s disease compared with controls, supporting that synaptotagmin-1 could be an early marker for Alzheimer’s disease. Here, SYT1 is linked to Alzheimer disease.